Investigating Its Role in Chronic Pain and Recovery
A New Frontier in Functional Medicine: Oral BPC-157 for Chronic Pain and Recovery
Can an oral peptide supplement deliver measurable results for pain and inflammation? In the first-ever human study on oral BPC-157, over 90% of participants experienced a reduction in pain—and more than 70% saw statistically significant and clinically meaningful relief on the validated PROMIS – Pain Intensity metric. Backed by research and trusted by leaders in functional medicine, Infiniwell’s BPC-157 Delayed Pro 500mcg is emerging as a powerful tool for supporting musculoskeletal healing, neuroprotection, and whole-body recovery.
An exploration of the science behind BPC-157, featuring insights from clinical experts and highlighting how this innovative peptide is emerging as a promising tool in evidence-informed functional medicine.